Priority Date: 01.02.12 (US 201261593664P)

NOVEL CYSTEINE PROTEASE INHIBITORS AND USES THEREOF

  • Application ID: EP13743556
  • Status: GRANT OF PATENT INTENDED

Applicant

Attorney

no operation time available
Headquarter in Birmingham and 7 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Barker Brettell LLP is specialized in A61. Barker Brettell LLP is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 01.02.2012 - Priority Date (US 201261593664P)
  • 08.08.2013 - Publication A1 (WO2013116663)
  • 17.12.2014 - Publication A1 (EP2811999)

IPC Classification